Companies:
49,829
Total Market Cap:
139401228918977.92
Global Rank
#30532
Country Rank
#533
Market Cap
45.29 M
Price
0.0544
Change (%)
2.13%
Volume
52,300
Cengild Medical Berhad's latest marketcap:
45.29 M
As of 07/05/2025, Cengild Medical Berhad's market capitalization has reached $45.29 M. According to our data, Cengild Medical Berhad is the 30532th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 45.29 M |
| Revenue (ttm) | 18.24 M |
| Net Income (ttm) | 2.45 M |
| Shares Out | 832.91 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 02/12/2025 |
| Earnings Date | 08/22/2025 |
Market Cap Chart
Data Updated: 07/05/2025
Cengild Medical Berhad's yearly market capitalization.
Cengild Medical Berhad has seen its market value drop from RM429.87 M to RM45.29 M since 2022, representing a total decrease of 89.46% and an annual compound decline rate (CAGR) of 59.12%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | RM45.29 M | -16.36% | 30532 |
| 12/31/2024 | RM229.05 M | -17.91% | 27842 |
| 12/29/2023 | RM279.03 M | -35.09% | 26457 |
| 12/30/2022 | RM429.87 M | 22464 |
Company Profile
About Cengild Medical Berhad
Cengild Medical Berhad is an investment holding company that operates a specialized medical center in Malaysia. Established in 2017 and headquartered in Kuala Lumpur, the company delivers a comprehensive range of healthcare services.
Core Services
- Specialized Care: Treatment for gastrointestinal and liver diseases, morbid obesity, oncology, and urological conditions.
- Medical Assessments: General cardiology, gynecology, gastroenterology, hepatology, and internal medicine consultations.
- Surgical Expertise: Procedures in anesthesiology, general surgery, orthopedic, plastic and reconstructive surgery, thoracic surgery, and ENT (ear, nose, and throat).
- Gastrointestinal Surgeries: Upper gastrointestinal, hepatobiliary, pancreatic, colorectal, and bariatric surgeries.
- Oncology Services: Chemotherapy and related cancer care treatments.
Additional Healthcare Offerings
- Medical management and nursing services.
- Clinical laboratory, pharmacy, radiology, and imaging services.
- Dietetics, nutrition, physiotherapy, and medical record management.
- Accident and emergency care, along with health screening programs.
Frequently Asked Questions
-
What is Cengild Medical Berhad's (KLSE-CENGILD) current market cap?As of 07/05/2025, Cengild Medical Berhad (including the parent company, if applicable) has an estimated market capitalization of $45.29 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Cengild Medical Berhad (KLSE-CENGILD) rank globally by market cap?Cengild Medical Berhad global market capitalization ranking is approximately 30532 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.